Orally Administrable Opioid Formulations Having Extended Duration of Effect

Details for Australian Patent Application No. 2005201142 (hide)

International Classifications

Event Publications

7 April 2005 Application Open to Public Inspection

Published as AU-B-2005201142

7 April 2005 Complete Application Filed

15 January 2009 Application Accepted

Published as AU-B-2005201142

2 April 2009 Alteration of Name

The name of the applicant has been altered to Euro-Celtique S.A.

14 May 2009 Standard Patent Sealed

3 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.